Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians

Abstract

Background Information asymmetries and the agency relationship are two defining features of the healthcare system. These market failures are often used as a rationale for government intervention. Many countries have government financing and provision of healthcare in order to correct for this, while health technology agencies also exist to improve efficiency. However, informational asymmetries and the resulting principal-agent problem still persist, and one example is the lack of cost awareness amongst clinicians. This study explores the cost awareness of clinicians across different settings. Methods We targeted four clinical cohorts: medical students, Senior House Officers/Interns, Mid-grade Senior Registrar/Residents, and Consultant/Attending Physicians, in six hospitals in the United Kingdom, the United States, Australia, New Zealand and Spain. The survey asked respondents to report the cost (as they recalled) of different types of scans, visits, medications and tests. Our analysis focused on the differential between the perceived/recalled cost and the actual cost. We explored variation across speciality, country and other potential confounders. Cost-awareness levels were estimated based on the cost estimates within 25% of the actual cost. Results We received 705 complete responses from six sites across five countries. Our analysis found that respondents often overestimated the cost of common tests while underestimating high-cost tests. The mean cost-awareness levels varied between 4 and 23% for different items. Respondents acknowledged that they did not feel they had received adequate training in cost awareness. Discussion The current financial climate means that cost awareness and the appropriate use of scarce healthcare resources is more paramount than perhaps ever before. Much of the focus of health economics research is on high-cost innovative technologies, yet there is considerable waste in the system with respect to overtreatment and overdiagnosis. Common reasons put forward for this include defensive medicine, poor education, clinical uncertainty and the institution of protocols. Conclusion Given the role of clinicians in the healthcare system, as agents both for patients and for providers, more needs to be done to remove informational asymmetries and improve clinician cost awareness. Supplementary Information The online version contains supplementary material available at 10.1007/s40258-022-00736-x.

From Allegations to Actions: Examining the Impact of Fraud Reporting Mechanisms in Healthcare

“…Information asymmetry occurs in healthcare because patients lack the medical expertise that healthcare providers possess. Patients rely on health providers to work in their best interests without con ict because of this information asymmetry (Fabes et al, 2022). Numerous authors have studied the effects of asymmetric information on the value and cost of medical care since Kenneth Arrow introduced the topic of asymmetric information in health insurance (Major, 2019).…”

‘But what if you miss something …?’: factors that influence medical student consideration of cost in decision making

“…Although written more than 35 years ago, this statement is even more pertinent today when the relentless increase in health care costs is a threat to the future of health care in many different countries [2][3][4]. Yet, although cost-conscious care is clearly critical for healthcare sustainability, evidence suggests that most doctors do not consider the costs of tests, equipment, medications and so on in their clinical decision making [5][6][7].…”

Patient Perceptions of Incentive-Linked Prescribing in Pakistan

“…Within this context, intense competition on the pharmaceutical industry's side means companies will allocate speci c budgets for incentivisation. [4] Our previous research suggests doctors are likely to accept incentives as they can provide opportunities to ful ll socially desired standards of living [2]. Other studies in Pakistan have also been highlighting the mechanisms through which ILP happens, how ILP can lead doctors to prescribe unnecessary medications, and how this distorted prescribing behaviour can lead to negative health and nancial outcomes for patients.…”

“…In this paper, we focus on incentive-linked prescribing (ILP), a practice where healthcare providers accept incentives from pharmaceutical companies for prescribing promoted medications. [1,2] ILP is more likely to take place in settings where the private sector is responsible for the majority of health care provision and a lack of regulatory control. In Pakistan, a country where over 75% of the healthcare utilisation is sought from the private healthcare sector, ILP is a pressing issue.…”